News For All Ireland (Telegram)
A power that only the people to get her can get back.
Legislation allowing for restrictions on indoor hospitality will be kept in place for another three months as a โsafety netโ in case something happens with Covid-19 during the winter, Minister for Health Stephen Donnelly has said.
He told the Dรกil that Ireland is on course to remove existing restrictions on October 22nd based on 90 per cent, or close to that figure, of people aged 16 or over being fully vaccinated.
A power that only the people to get her can get back.
Legislation allowing for restrictions on indoor hospitality will be kept in place for another three months as a โsafety netโ in case something happens with Covid-19 during the winter, Minister for Health Stephen Donnelly has said.
He told the Dรกil that Ireland is on course to remove existing restrictions on October 22nd based on 90 per cent, or close to that figure, of people aged 16 or over being fully vaccinated.
News For All Ireland (Telegram)
Building your immune system naturally is just a conspiracy.
The HSE is urging the public to get a flu vaccine this winter amid concerns over a more โsevere flu season this yearโ.
Director of the HSEโs National Immunisation Office Dr Lucy Jessop, said practices such as masks wearing, travel restrictions and social distancing which have protected the public against Covid-19, also protected people from seasonal flu last year.
She said this could lead to flu circulating more widely in the community in the coming months.
Building your immune system naturally is just a conspiracy.
The HSE is urging the public to get a flu vaccine this winter amid concerns over a more โsevere flu season this yearโ.
Director of the HSEโs National Immunisation Office Dr Lucy Jessop, said practices such as masks wearing, travel restrictions and social distancing which have protected the public against Covid-19, also protected people from seasonal flu last year.
She said this could lead to flu circulating more widely in the community in the coming months.
News For All Ireland (Telegram)
Australia ๐ฆ๐บ look and watch carefully it's going to happen worldwide.
Australia ๐ฆ๐บ look and watch carefully it's going to happen worldwide.
This media is not supported in your browser
VIEW IN TELEGRAM
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
Oh my.... Medical Think Tank Conference 2019. Oct 29, 11 days after Event 201 Simulation, 20 days before the 1st case at Wuhan... Listen to the last 20 secs, Rick Bright says " Its not crazy to think a Novel Avian Virus could cause an outbreak in China"...
Oh my.... Medical Think Tank Conference 2019. Oct 29, 11 days after Event 201 Simulation, 20 days before the 1st case at Wuhan... Listen to the last 20 secs, Rick Bright says " Its not crazy to think a Novel Avian Virus could cause an outbreak in China"...
Emil Kalinowski (The Banking Crisis Nobody Is Talking About: Deep Dive)
George Gammon (YouTube)
George Gammon (YouTube)
YouTube
Emil Kalinowski (The Banking Crisis Nobody Is Talking About: Deep Dive)
Check out the next Rebel Capitalist Live at https://www.rebelcapitalistlive.com
โ LYN ALDEN and I discuss portfolio that will HELP YOU profit from DOLLAR losing reserve currency status, click this link to check it out!! ๐ฅ https://www.georgegammon.com/portfolioโฆ
โ LYN ALDEN and I discuss portfolio that will HELP YOU profit from DOLLAR losing reserve currency status, click this link to check it out!! ๐ฅ https://www.georgegammon.com/portfolioโฆ
News For All Ireland (Telegram)
International tourists will not be welcomed back to Australia until next year, with the return of skilled migrants and students given higher priority, the prime minister said.
Prime Minister Scott Morrison said Australia was expected to reach the benchmark of 80% of the population aged 16 and older having a second dose.
International tourists will not be welcomed back to Australia until next year, with the return of skilled migrants and students given higher priority, the prime minister said.
Prime Minister Scott Morrison said Australia was expected to reach the benchmark of 80% of the population aged 16 and older having a second dose.
Forwarded from Ms P
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
RT @NeverSleever: Never Forget... 99+% Survival Rate...
RT @NeverSleever: Never Forget... 99+% Survival Rate...
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
RT @Resist_05: Dear NSW business owners.. if you mandate the vaccines on your staff.. under new legislation you will be held liable for adverse events and DEATHS..!
https://www.parliament.nsw.gov.au/bill/files/3835/First%20Print.pdf https://twitter.com/Resist_05/status/1445578512006406154/photo/1
RT @Resist_05: Dear NSW business owners.. if you mandate the vaccines on your staff.. under new legislation you will be held liable for adverse events and DEATHS..!
https://www.parliament.nsw.gov.au/bill/files/3835/First%20Print.pdf https://twitter.com/Resist_05/status/1445578512006406154/photo/1
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
RT @LeeHurstComic: Go back 5 years. Imagine if someone said you had to have an injection to go into a pub, restaurant, cinema, theatre.
What the actual fk have we descended into?
This world can go fk itself.
RT @LeeHurstComic: Go back 5 years. Imagine if someone said you had to have an injection to go into a pub, restaurant, cinema, theatre.
What the actual fk have we descended into?
This world can go fk itself.
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
If your job requires the WAX, it's simple, change your job...Choose LIFE, because trust me, nothing else matters when you're DEAD.....
If your job requires the WAX, it's simple, change your job...Choose LIFE, because trust me, nothing else matters when you're DEAD.....
Likewise, mass vaccination campaigns may have a beneficial short-time effect in that they reduce viral spread and protect vulnerable people from disease (e.g., elderly people and those with underlying disease), but will eventually drive the propagation of more infectious variants. Dominant circulation of the latter will lead to a resurgence of viral infectious pressure, thereby eroding the innate immune defense of the unvaccinated (i.e., mostly younger age groups including children) and thus making them more susceptible to contracting Covid-19 disease. This already explains why mass vaccination campaigns conducted in the middle of a pandemic will only cause Sars-CoV-2 to engender more disease and claim more human lives. Because of this mass vaccination program, waves of morbidity will continue for much longer, as more (recovery from) disease cases will be required to compensate for the erosion of the populationโs innate immunity and, therefore, to make up for the latterโs deficient contribution to HI.
When one considers that all of these effects, whether beneficial or detrimental, will mutually interfere and that the average of population segments that are adversely or favorably affected by the overall impact of this multifactorial phenomenon will shift over time, it can become very complex and challenging to elucidate whether any single human influence has a beneficial or detrimental impact. It all depends on what โendpointโ (e.g., protection against infection versus protection against disease) one is looking at in which part of the population at which stage of the pandemic and within which environmental context. On the other hand, the extent of infection-prevention measures, the distribution of vaccine coverage rates and the time point of emergence of new dominant circulating variants and their level of infectiousness may dramatically differ between countries/ regions and so will the corresponding โsnapshotโ results recorded for a particular country/ region.
This is why experts currently look at the impact of mass vaccination campaigns either as at a glass that is half full (โthe vaccines workโ!) or one that is half empty (โthe vaccines donโt work well enoughโ). That is precisely THE issue: A vaccine that only prevents hospitalizations and severe Covid-19 disease is not good enough to be used to combat a pandemic. From a global or even public health perspective, these are, therefore, not the right criteria to evaluate the success of mass vaccination campaigns deployed during a pandemic. Using these criteria as an indicator of the level of control over the pandemic will inevitably lead to a further escalation of this morbidity and mortality rates. There should be no doubt that non-transmission-blocking vaccines (i.e., so-called โleakyโ or โimperfectโ vaccines) can never ever control a pandemic, even though they may temporarily protect against disease. Only temporarily? Yes, indeed. Given the globally increasing immune pressure and concomitant infectious viral pressure, genomic epidemiologists have no doubt that this pandemic roller coaster will not stop before it takes us over the cliff into the abyss of complete viral resistance to anti-spike (S) antibodies. That is where all runaway trains of the different ongoing pandemics of highly infectious variants will be coming together and converge into a big whirl where they can no longer be distinguished from one another. The first stages of this evolution is what we now begin to see in countries which have already massively vaccinated their population (e.g., Israel). There is no doubt that other countries like the United Kingdom and the United States will soon go down the same path. Due to increasing resistance to neutralizing anti-S antibodies (Abs), these countries are now even beginning to shift from a primarily beneficial (i.e., less susceptible to severe disease) to a primarily detrimental effect (more susceptible to severe disease) in the vaccinated as compared to the unvaccinated
When one considers that all of these effects, whether beneficial or detrimental, will mutually interfere and that the average of population segments that are adversely or favorably affected by the overall impact of this multifactorial phenomenon will shift over time, it can become very complex and challenging to elucidate whether any single human influence has a beneficial or detrimental impact. It all depends on what โendpointโ (e.g., protection against infection versus protection against disease) one is looking at in which part of the population at which stage of the pandemic and within which environmental context. On the other hand, the extent of infection-prevention measures, the distribution of vaccine coverage rates and the time point of emergence of new dominant circulating variants and their level of infectiousness may dramatically differ between countries/ regions and so will the corresponding โsnapshotโ results recorded for a particular country/ region.
This is why experts currently look at the impact of mass vaccination campaigns either as at a glass that is half full (โthe vaccines workโ!) or one that is half empty (โthe vaccines donโt work well enoughโ). That is precisely THE issue: A vaccine that only prevents hospitalizations and severe Covid-19 disease is not good enough to be used to combat a pandemic. From a global or even public health perspective, these are, therefore, not the right criteria to evaluate the success of mass vaccination campaigns deployed during a pandemic. Using these criteria as an indicator of the level of control over the pandemic will inevitably lead to a further escalation of this morbidity and mortality rates. There should be no doubt that non-transmission-blocking vaccines (i.e., so-called โleakyโ or โimperfectโ vaccines) can never ever control a pandemic, even though they may temporarily protect against disease. Only temporarily? Yes, indeed. Given the globally increasing immune pressure and concomitant infectious viral pressure, genomic epidemiologists have no doubt that this pandemic roller coaster will not stop before it takes us over the cliff into the abyss of complete viral resistance to anti-spike (S) antibodies. That is where all runaway trains of the different ongoing pandemics of highly infectious variants will be coming together and converge into a big whirl where they can no longer be distinguished from one another. The first stages of this evolution is what we now begin to see in countries which have already massively vaccinated their population (e.g., Israel). There is no doubt that other countries like the United Kingdom and the United States will soon go down the same path. Due to increasing resistance to neutralizing anti-S antibodies (Abs), these countries are now even beginning to shift from a primarily beneficial (i.e., less susceptible to severe disease) to a primarily detrimental effect (more susceptible to severe disease) in the vaccinated as compared to the unvaccinated
(https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201).
The current situation is highly problematic as ALL segments of the population will dramatically suffer from a situation where anti-S Abs still bind strongly enough to suppress the vaccineeโs innate immune response against non-mutable, highly conserved Coronavirus (CoV) motifs while no longer being able to sufficiently neutralize highly infectious variants. Instead, poor binding affinity of anti-RBD (receptor-binding domain) Abs to Sars-CoV-2 S protein as a result of mutations in the N-terminal domain (NTD) could tip the scale in favor of infection-enhancing Abs and thereby make vaccinees prone to suffering Ab-dependent enhancement (ADE) of Covid-19 disease (1) (Liu et al., 2021; Yahi N et al., 2021).
Viral resistance to these S-specific Abs is a terrifying thought as spike protein is not only required but sufficient for enabling CoV infectiousness and pathogenicity (Belouzard S, 2012; Weiss and Navas-Martin, 2005). This underscores the importance for each and every Public Health authority to look beyond the end of their nose to understand where this train is heading instead of focusing on intermediate stations (snapshots!) that โ in contrast to the end station - look extremely different depending on a number of population-specific environmental and human influences.
Correlation does not imply causation!
As distinct types and dynamics of protection are now concomitantly shaping the โphenotypicโ characteristics of the pandemic, some people tend to make conclusions that are merely based on correlations. However, correlation does not imply causation. The most telling example of this can be found in countries which dramatically scaled up their mass vaccination campaigns in the midst of a spectacular surge of cases. The subsequently observed decline of morbidity and mortality rates is often attributed to the โsuccessโ of the aggressive mass vaccination campaign (e.g., in UK, Israel and, more recently, in India where a steep decline in cases occurred in Jan-Feb 2021 and May-June 2021, respectively). However, many elements argue against the conclusion that mass vaccination triggered the rapid and dramatic decrease in cases. First, these mass vaccination campaigns were flanked by stringent infection-prevention measures, even including lockdowns (e.g., UK, Israel) and have, more recently, been shown to not prevent transmission of highly infectious variants (such as the Delta variant). Secondarily, it is well known that natural immunity in its own right can abrogate a surge in cases during a natural pandemic and result in a steep decline of viral infectivity rates. The latter always results from the combined effect of naturally acquired antigen-specific immunity following recovery from disease (typically occurring in the more vulnerable part of the population) and innate oligospecific immunity that serves as the first โgeneralistโ line of immune defense, particularly in younger and healthy age groups. These are the cornerstones on which herd immunity will eventually be established. Mass vaccination can only contribute to a decline in cases to the extent that it diminishes viral transmission and, hence, the likelihood for young and healthy people to become re-exposed to Sars-CoV-2 shortly after their previous infection, i.e. at a point in time where they become susceptible to the disease because of temporary suppression of their innate oligospecific Abs (Vanden Bossche, August 2021). As already mentioned, though, the beneficial effect of mass vaccination on viral transmission is only of short duration as universal vaccination campaigns provide more infectious immune escape variants with a competitive advantage and eventually enable them to reproduce more effectively.
The current situation is highly problematic as ALL segments of the population will dramatically suffer from a situation where anti-S Abs still bind strongly enough to suppress the vaccineeโs innate immune response against non-mutable, highly conserved Coronavirus (CoV) motifs while no longer being able to sufficiently neutralize highly infectious variants. Instead, poor binding affinity of anti-RBD (receptor-binding domain) Abs to Sars-CoV-2 S protein as a result of mutations in the N-terminal domain (NTD) could tip the scale in favor of infection-enhancing Abs and thereby make vaccinees prone to suffering Ab-dependent enhancement (ADE) of Covid-19 disease (1) (Liu et al., 2021; Yahi N et al., 2021).
Viral resistance to these S-specific Abs is a terrifying thought as spike protein is not only required but sufficient for enabling CoV infectiousness and pathogenicity (Belouzard S, 2012; Weiss and Navas-Martin, 2005). This underscores the importance for each and every Public Health authority to look beyond the end of their nose to understand where this train is heading instead of focusing on intermediate stations (snapshots!) that โ in contrast to the end station - look extremely different depending on a number of population-specific environmental and human influences.
Correlation does not imply causation!
As distinct types and dynamics of protection are now concomitantly shaping the โphenotypicโ characteristics of the pandemic, some people tend to make conclusions that are merely based on correlations. However, correlation does not imply causation. The most telling example of this can be found in countries which dramatically scaled up their mass vaccination campaigns in the midst of a spectacular surge of cases. The subsequently observed decline of morbidity and mortality rates is often attributed to the โsuccessโ of the aggressive mass vaccination campaign (e.g., in UK, Israel and, more recently, in India where a steep decline in cases occurred in Jan-Feb 2021 and May-June 2021, respectively). However, many elements argue against the conclusion that mass vaccination triggered the rapid and dramatic decrease in cases. First, these mass vaccination campaigns were flanked by stringent infection-prevention measures, even including lockdowns (e.g., UK, Israel) and have, more recently, been shown to not prevent transmission of highly infectious variants (such as the Delta variant). Secondarily, it is well known that natural immunity in its own right can abrogate a surge in cases during a natural pandemic and result in a steep decline of viral infectivity rates. The latter always results from the combined effect of naturally acquired antigen-specific immunity following recovery from disease (typically occurring in the more vulnerable part of the population) and innate oligospecific immunity that serves as the first โgeneralistโ line of immune defense, particularly in younger and healthy age groups. These are the cornerstones on which herd immunity will eventually be established. Mass vaccination can only contribute to a decline in cases to the extent that it diminishes viral transmission and, hence, the likelihood for young and healthy people to become re-exposed to Sars-CoV-2 shortly after their previous infection, i.e. at a point in time where they become susceptible to the disease because of temporary suppression of their innate oligospecific Abs (Vanden Bossche, August 2021). As already mentioned, though, the beneficial effect of mass vaccination on viral transmission is only of short duration as universal vaccination campaigns provide more infectious immune escape variants with a competitive advantage and eventually enable them to reproduce more effectively.
GOV.UK
Investigation of SARS-CoV-2 variants of concern: technical briefings
Technical briefing documents on novel SARS-CoV-2 variants.
India, for example, has recently been witnessing a spectacular decline in cases although clear evidence has been provided that Covid-19 vaccines have, if at all, only minor impact on transmission of the highly infectious Delta variant, which was responsible for Indiaโs surge in cases during April-May 2021. This is unambiguous proof that the steep decline in cases was primarily caused by immune defense mechanisms that were not based on protection from disease (as provided by Covid-19 vaccines) but on protection from infection and transmission (2) (as provided by natural immunity). Innate polyreactive Abs that are directed against non-mutable common structures of otherwise highly mutable CoVs likely protect against all kinds of different CoVs, including their variants. This is in sharp contrast to anti-S-specific vaccinal Abs, which can escape from spike variants. It is fair, therefore, to conclude that mass vaccination campaigns are not responsible for the abrupt decline of cases observed after a prominent surge but that this effect is primarily due to the sterilizing effect of both acquired and innate antiviral immunity. This clearly illustrates that declines in surges that are correlated with an aggressive roll-out of mass vaccination campaigns do not imply that these campaigns are the cause of the decline.
Conclusively, mass vaccination campaigns during a pandemic of highly infectious variants fail to control viral transmission. Instead of contributing to building HI, they dramatically delay natural establishment of HI (Vanden Bossche, August 2021). This is why the ongoing universal vaccination campaigns are absolutely detrimental to public and global health.
Separating the wheat from the chaff
The above examples already illustrate why it is so critical to separate the wheat from the chaff and to not even consider advice from people, sometimes even scientists, who have no profound understanding of the dynamics of host-pathogen interactions. They are simply unable to understand that the outcome of these interactions continuously evolves as a result of changing infectious viral pressure due to changing environmental conditions. People, no matter their names and reputation, who are not knowledgeable in the fields of immunology, virology, vaccinology and evolutionary biology/ epidemiology are, therefore, not a good source for information or advice. This particularly applies to politicians. The vast majority of them are not only scientifically illiterate but they are typically also unable or unwilling to work in a mid- or long-term perspective. Because they have no understanding whatsoever of the evolutionary dynamics of this pandemic, they simply do not understand that the rise in cases of disease currently observed in a number of European countries as well as in the US is due to enhanced circulation of more infectious variants that enjoy exceptional training as mass vaccination only increases the immune pressure exerted by the overall population. Their simplistic reasoning make them conclude that vaccinating the unvaccinated (i.e., younger age groups and children) is going to solve the problem, whereas each and every independent (!) knowledgeable expert understands that this is only going to further raise the population-level immune pressure on viral infectiousness and, therefore, promote the adaptation of additional mutations that will eventually enable full neutralization escape of circulating, highly infectious variants (Vanden Bossche, June 2021).
Are my peers from the Vaccine Industry not allowed to engage in a scientific discussion, or maybe not even allowed to talk at all?
It was no later than early March 2021 when, in response to my call urging all Global Health organizations and influential regulatory agencies to stop mass vaccination, that I received a reply of one of the most renown vaccinologists on this planet, a true icon in the field of vaccinology.
Conclusively, mass vaccination campaigns during a pandemic of highly infectious variants fail to control viral transmission. Instead of contributing to building HI, they dramatically delay natural establishment of HI (Vanden Bossche, August 2021). This is why the ongoing universal vaccination campaigns are absolutely detrimental to public and global health.
Separating the wheat from the chaff
The above examples already illustrate why it is so critical to separate the wheat from the chaff and to not even consider advice from people, sometimes even scientists, who have no profound understanding of the dynamics of host-pathogen interactions. They are simply unable to understand that the outcome of these interactions continuously evolves as a result of changing infectious viral pressure due to changing environmental conditions. People, no matter their names and reputation, who are not knowledgeable in the fields of immunology, virology, vaccinology and evolutionary biology/ epidemiology are, therefore, not a good source for information or advice. This particularly applies to politicians. The vast majority of them are not only scientifically illiterate but they are typically also unable or unwilling to work in a mid- or long-term perspective. Because they have no understanding whatsoever of the evolutionary dynamics of this pandemic, they simply do not understand that the rise in cases of disease currently observed in a number of European countries as well as in the US is due to enhanced circulation of more infectious variants that enjoy exceptional training as mass vaccination only increases the immune pressure exerted by the overall population. Their simplistic reasoning make them conclude that vaccinating the unvaccinated (i.e., younger age groups and children) is going to solve the problem, whereas each and every independent (!) knowledgeable expert understands that this is only going to further raise the population-level immune pressure on viral infectiousness and, therefore, promote the adaptation of additional mutations that will eventually enable full neutralization escape of circulating, highly infectious variants (Vanden Bossche, June 2021).
Are my peers from the Vaccine Industry not allowed to engage in a scientific discussion, or maybe not even allowed to talk at all?
It was no later than early March 2021 when, in response to my call urging all Global Health organizations and influential regulatory agencies to stop mass vaccination, that I received a reply of one of the most renown vaccinologists on this planet, a true icon in the field of vaccinology.
He was courageous enough to share that I was right and that these vaccines would basically only breed new variants but that it would not be worth going against the current because people would not listen. That is when I realized that a narrative started to circulate that used whatever possible tools in trying to invalidate and destroy any argument that scrutinizes the rationale behind the mass vaccination program, even though it could be predicted for a fact by any experienced vaccinologist that such an experiment would not lead to a happy end, and certainly not to herd immunity. If this person spoke out, neither the WHO nor any other international or public health organization would have had a choice other than to give the mass vaccination program at least a second thought. Itโs likely, however, that the top vaccinologists on the globe appeared to think it was more prudent to keep quiet while hoping they could soon make up for the bad start by designing a โsmarterโ approach for a second-generation vaccine.
https://www.geertvandenbossche.org/post/the-last-post
https://www.geertvandenbossche.org/post/the-last-post
Geert Vanden Bossche
The Last Post
Whoโs wrong, whoโs right? These are the key points one has to understand to be able to capture the never-ending discussion on whether or not mass vaccination campaigns work
โ๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
RT @MichaelPSenger: This link contains the full 24-page report: PCR test orders soared in China beginning in May 2019, a full 7 months before China reported its first coronavirus cases.
https://humanevents.com/2021/10/04/breaking-china-pcr-test-orders-soared-before-first-reported-covid-case-government-contracts-show-surges-in-wuhan-area-purchases-starting-may-2019/
RT @MichaelPSenger: This link contains the full 24-page report: PCR test orders soared in China beginning in May 2019, a full 7 months before China reported its first coronavirus cases.
https://humanevents.com/2021/10/04/breaking-china-pcr-test-orders-soared-before-first-reported-covid-case-government-contracts-show-surges-in-wuhan-area-purchases-starting-may-2019/
Human Events
BREAKING: China PCR Test Orders Soared Before First Reported COVID Case, Government Contracts Show Surges in Wuhan-Area Purchasesโฆ
According to a new report, there was a dramatic increase in PCR test orders in China during the second half of 2019, prior to the first reported case of COVID-19. The study, conducted by Internet 2.0, concludes that based on the data analyze
This media is not supported in your browser
VIEW IN TELEGRAM
๐๐๐๐ ๐๐๐๐ฝ๐๐๐๐๐ (Twitter)
RT @MichaelPSenger: Haunting full-color images of Warsaw in 1945.
Oh wait, noโthis is Melbourne, Australia. In 2021.
https://twitter.com/AnonCitizenUK/status/1445376807063142400/video/1
RT @MichaelPSenger: Haunting full-color images of Warsaw in 1945.
Oh wait, noโthis is Melbourne, Australia. In 2021.
https://twitter.com/AnonCitizenUK/status/1445376807063142400/video/1